Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-11-02-2002
Volume26
Issue 11

Residual Solvent Analysis in Pharmaceuticals

Author(s):

Anil M. Dwivedi, PhD

The author discusses the current pharmacopeial status of the acceptance limits and classifications of pharmaceutical residual solvents.

External Link - article-38267.pdf

Articles in this issue
Contract Services
Major Changes Ahead for FDA
Estimation of Distribution Coefficients from the Partition Coefficient and pKa
Residual Solvent Analysis in Pharmaceuticals
Preparation and In Vitro Evaluation of Miconazole Nitrate-Loaded Topical Liposomes

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
PharmTech Weekly News Roundup
Related Content
Ozempic, Mounjaro and Wegovy injectable pens on white background | Image Credit: © K KStock - stock.adobe.com
September 17th 2025

Lilly, Novo, Hims Get FDA Warnings About Misleading Drug Communications

Patrick Lavery
Drug Solutions Podcast: Sustainable Solutions for Biopharma
September 17th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
Site Logo
September 17th 2025

Bringing novel ADC formats into the clinic

Lonza
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
September 17th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
Site Logo
September 17th 2025

BETTER, FASTER SMALL-MOLECULE SYNTHESIS: LEVERAGING MODERN TOOLS TO EVALUATE AND OPTIMIZE PROCESS CHEMISTRY

Lonza
Digital composite of highlighted red painful liver of woman | Image credit: ©mi_viri -stock.adobe.com
September 17th 2025

Competition in MASH is Heating Up as GLP-1s Gate-Crash the Party

Cheryl Barton
© 2025 MJH Life Sciences

All rights reserved.